FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Tris Pharma Recalls Infant Ibuprofen

[ Price : $8.95]

Tris Pharma recalls three lots of infant ibuprofen concentrated oral suspension (50 mg per 1.25 mL) due to the potential for the p...

FDA Wants Food Handler Antiseptic Product Info

[ Price : $8.95]

FDA opens a docket for stakeholder comments and data on the safety and effectiveness of antiseptic products intended for use in co...

Yates Memo Accountability Eased

[ Price : $8.95]

Attorney Anne Walsh outlines Justice Department changes to the Yates memo on individual accountability in criminal and civil cases...

FTC Supports FDA Deterring Petition Abuse

[ Price : $8.95]

The Federal Trade Commission says it shares FDA concerns about abuse of the citizen petition process to delay approval of generic ...

6 Observations in Gadea Biopharma FDA-483

[ Price : $8.95]

FDA releases an FDA-483 with six observations from an inspection at Spains Gadea Biopharma.

Info Collection Extension for Drug Supply Chain Guide

[ Price : $8.95]

Federal Register notice: FDA has submitted to OMB an information collection extension entitled Guidance for Industry: Drug Supply ...

InSightecs Exablate Regulatory Review Period Determined

[ Price : $8.95]

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for InSightecs medical device E...

Info Collection Extension on Device e-Registration & Listing

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Electronic Submission of Medical Devic...

FDA Approves Olympus Device for Emphysema

[ Price : $8.95]

FDA approves Olympus Spiration Valve System for treating severe emphysema, a progressive form of chronic obstructive pulmonary dis...

Improvements to FDA Adaptive Design Guidance Praised

[ Price : $8.95]

PHRMA praises FDA for its new draft guidance on adaptive designs for clinical trials of drugs and biologics.